Abstract
Microtubules (MTs), which are highly dynamic assemblies of the protein tubulin, play important and diverse roles in eukaryotic cells. MT dynamics are regulated during the cell cycle by interacting with a large number of endogenous cellular regulators. In addition, many anti-tumour drugs and natural ligands that interact directly with tubulin are able to either stabilise or destabilise MTs and to disrupt the normal dynamics. Herein, we compare the structures of tubulin when complexed with different ligands in order to analyse: (i) various binding-sites of the protein and different positions of ligands within the microtubule (ii) the diverse effect on the microtubule dynamics. The structures and data given are essential for understanding tubulin-ligand interactions and their influence on the regulation of the microtubule system.
Keywords: Microtubules, microtubule-stabilising agent, structure based drug design, structure-activity relationship, tubulin, plus-end tracking proteins, Guanosine-5'-triphosphate, microtubule-associated proteins, microtubule-stabilising agent, microtubules, structure-activity relationship, stathmine-like domain, The tight complex tubulin/RB3-SLD
Current Cancer Drug Targets
Title:Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics
Volume: 12 Issue: 6
Author(s): E. Stec-Martyna, M. Ponassi, M. Miele, S. Parodi, L. Felli and C. Rosano
Affiliation:
Keywords: Microtubules, microtubule-stabilising agent, structure based drug design, structure-activity relationship, tubulin, plus-end tracking proteins, Guanosine-5'-triphosphate, microtubule-associated proteins, microtubule-stabilising agent, microtubules, structure-activity relationship, stathmine-like domain, The tight complex tubulin/RB3-SLD
Abstract: Microtubules (MTs), which are highly dynamic assemblies of the protein tubulin, play important and diverse roles in eukaryotic cells. MT dynamics are regulated during the cell cycle by interacting with a large number of endogenous cellular regulators. In addition, many anti-tumour drugs and natural ligands that interact directly with tubulin are able to either stabilise or destabilise MTs and to disrupt the normal dynamics. Herein, we compare the structures of tubulin when complexed with different ligands in order to analyse: (i) various binding-sites of the protein and different positions of ligands within the microtubule (ii) the diverse effect on the microtubule dynamics. The structures and data given are essential for understanding tubulin-ligand interactions and their influence on the regulation of the microtubule system.
Export Options
About this article
Cite this article as:
Stec-Martyna E., Ponassi M., Miele M., Parodi S., Felli L. and Rosano C., Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics, Current Cancer Drug Targets 2012; 12 (6) . https://dx.doi.org/10.2174/156800912801784893
DOI https://dx.doi.org/10.2174/156800912801784893 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone
Anti-Cancer Agents in Medicinal Chemistry New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases
Current Drug Targets An Update on Molecular Research of Pancreatic Adenocarcinoma
Anti-Cancer Agents in Medicinal Chemistry NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design Targeting Signalling Pathways in Hepatocellular Carcinoma
Current Pharmaceutical Design Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy
Current Medicinal Chemistry Targeting RSK: An Overview of Small Molecule Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Phytochemical, Anti-diabetic and Cardiovascular Properties of Urtica dioica L. (Urticaceae): A Review
Mini-Reviews in Medicinal Chemistry Development of Topical Nanocarriers for Skin Cancer Treatment Using Quality by Design Approach
Current Medicinal Chemistry Similar and Shared Nongenomic Mechanisms of Action of Estrogen and Thyroid Hormone
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Regulation of Autophagy Through Multiple Independent Hypoxic Signaling Pathways
Current Molecular Medicine Management of Connective Tissue Interstitial Lung Disease
Current Respiratory Medicine Reviews Editorial (Hot Topic: Biomarkers of Oxidative Stress and Cancer: From Chemistry, Biology to Clinical Applications and Personalized Therapy)
Current Molecular Medicine Acetylenic Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis
Combinatorial Chemistry & High Throughput Screening Recent Inventions in Powder Technology and Granular Science Incorporating Improved Drug Delivery
Recent Patents on Engineering Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Current Drug Metabolism Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry Acknowledgements to Reviewers:
Anti-Cancer Agents in Medicinal Chemistry Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
Anti-Cancer Agents in Medicinal Chemistry